Reflux Esophagitis (Gastroesophageal Reflux Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Reflux Esophagitis (Gastroesophageal Reflux Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

Summary

This reports provides a data-driven overview of the current and future competitive landscape in GERD therapeutics.

There will be more than 300 million prevalent cases of GERD in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast.

The marketed drugs space for GERD comprises both novel class of potassium-competitive acid blockers (P-CABs) and conventional delayed-release proton pump inhibitors (DR-PPIs).

R&D activity in GERD is promising with four drugs in pre-registration stage and five in Phase III development across global markets.

Commercial sponsors dominate clinical trial development in GERD, with the US emerging as the key country for conducting Phase III trials.

In deals involving companies developing GERD assets, acquisition was the most prevalent deal type globally during past two years.

Scope

GlobalData’s GERD: Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace. Components of the report include -

Disease Landscape

Disease Overview

Epidemiology Overview

Treatment Overview

Marketed Products Assessment

Breakdown by Mechanism of Action, Molecule Type, Route of Administration

Product Profiles with Sales Forecast

Pricing and Reimbursement Assessment

Annual Therapy Cost

Time to Pricing and Time to Reimbursement

Pipeline Assessment

Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration

Product Profiles with Sales Forecast

Late-to-mid-stage Pipeline Drugs

Phase Transition Success Rate and Likelihood of Approval

Clinical Trials Assessment

Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status

Enrolment Analytics, Site Analytics, Feasibility Analysis

Deals Landscape

Mergers, Acquisitions, and Strategic Alliances by Region

Overview of Recent Deals

Commercial Assessment

Key Market Players

Future Market Catalysts

Reasons to Buy

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the GERD market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global GERD market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.